Access to and use of $4 generic programs in medicare

Journal of General Internal Medicine

Volumn 27, Issue 10, 2012, Pages 1251-1257

  Zhang, Yuting ^a   Gellad, Walid F ^b,c   Zhou, Lei ^a,d   Lin, Yi Jen ^e   Lave, Judith R ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c RAND CORPORATION   (United States)

^d PharmaNet/i3   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Low cost generic drugs; Medicare; Pharmaceuticals

Indexed keywords

CHLORPROPAMIDE; FLUOXETINE; GENERIC DRUG; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HALOPERIDOL; MEVINOLIN; PRAVASTATIN; THIORIDAZINE;

AGED; ARTICLE; COMORBIDITY; COST CONTROL; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH STATUS; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBSERVATIONAL STUDY; PHARMACY; PRESCRIPTION; RURAL AREA; SOCIOECONOMICS; TRAVEL;

AGED; AGED, 80 AND OVER; DRUGS, GENERIC; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICARE PART D; UNITED STATES;

EID: 84866917262     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-1993-9     Document Type: Article

References (13)

1. Wal-Mart Stores Inc. Affordable prescription program. http://walmartstores.com/healthwellness/8247.aspx. Accessed May 4, 2011.
2. Target.com. Target 4 dollar listing. http://sites.target.com/site/en/ health/page.jsp?contentId=PRD03-004319. Accessed January 10, 2010.
3. Kaiser Family Foundation. Prescription Drug Trends. http://kff.org/ rxdrugs/3057.cfm. Accessed February 18, 2010.
4. Kaiser Family Foundation. Medicare prescription drug plans in 2010 and key changes over five years: summary of findings. 2010; http://www.kff.org/ medicare/upload/8096.pdf. Accessed September 1, 2011.
5. Zhang Y, Zhou L, Gellad WF. Potential savings from greater use of $4 generic drugs. Arch Intern Med. 2011;171(5):468-9.
6. Kaiser Family Foundation. Health care on a budget: the financial burden of health spending by Medicare households. http://kff.org/medicare/upload/8171. pdf. Accessed April 26, 2011.
7. Bonito A, Bann C, Eicheldinger C, Carpenter L. Creation of New Race- Ethnicity Codes and Socioeconomic Status (SES) Indicators for Medicare Beneficiaries. Final Report. Sub-Task 2. (Prepared by RTI International for the Centers for Medicare and Medicaid Services through an interagency agreement with the Agency for Healthcare Research and Policy, under Contract No. 500-00-0024, Task No. 21). http://www.ahrq.gov/qual/medicareindicators/medicareindicators. pdf. Accessed March 16, 2010.
8. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
9. Centers for Medicare & Medicaid Services. Centers for Medicare & Medicaid Services Prescription Drug Hierarchical Condition Category (RxHCC) Model Software. 2010; http://www.cms.hhs.gov/MedicareAdvtgSpecRateStats/06-Risk- adjustment.asp. Accessed February 3, 2010.
10. Eisenberg JM, Power EJ. Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA. 2000;284(16):2100-7.
11. AAA Association Communication. Your driving costs. http://www. aaaexchange.com/Assets/Files/20073261133460.YourDrivingCosts2007.pdf. Accessed April 12, 2011.
12. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 14 Coordination of Benefits, Page 19. Baltimore, MD, USA 2008.
13. Choudhry NK, Shrank WH. Four-Dollar Generics - Increased Accessibility, Impaired Quality Assurance. N Engl J Med. 2010;363 (20):1885-7.